Titre : Chromosomes humains

Chromosomes humains : Questions médicales fréquentes

Termes MeSH sélectionnés :

Early Detection of Cancer
{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "Chromosomes humains : Questions médicales les plus fréquentes", "headline": "Chromosomes humains : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les Chromosomes humains : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-07-04", "dateModified": "2025-03-31", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "Chromosomes humains" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Chromosomes de mammifère", "url": "https://questionsmedicales.fr/mesh/D033481", "about": { "@type": "MedicalCondition", "name": "Chromosomes de mammifère", "code": { "@type": "MedicalCode", "code": "D033481", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "G05.360.162.520" } } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Chromosomes humains 1-3", "alternateName": "Chromosomes, Human, 1-3", "url": "https://questionsmedicales.fr/mesh/D002900", "about": { "@type": "MedicalCondition", "name": "Chromosomes humains 1-3", "code": { "@type": "MedicalCode", "code": "D002900", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "G05.360.162.520.300.235" } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Chromosomes humains de la paire 1", "alternateName": "Chromosomes, Human, Pair 1", "url": "https://questionsmedicales.fr/mesh/D002878", "about": { "@type": "MedicalCondition", "name": "Chromosomes humains de la paire 1", "code": { "@type": "MedicalCode", "code": "D002878", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "G05.360.162.520.300.235.240" } } }, { "@type": "MedicalWebPage", "name": "Chromosomes humains de la paire 2", "alternateName": "Chromosomes, Human, Pair 2", "url": "https://questionsmedicales.fr/mesh/D002889", "about": { "@type": "MedicalCondition", "name": "Chromosomes humains de la paire 2", "code": { "@type": "MedicalCode", "code": "D002889", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "G05.360.162.520.300.235.245" } } }, { "@type": "MedicalWebPage", "name": "Chromosomes humains de la paire 3", "alternateName": "Chromosomes, Human, Pair 3", "url": "https://questionsmedicales.fr/mesh/D002893", "about": { "@type": "MedicalCondition", "name": "Chromosomes humains de la paire 3", "code": { "@type": "MedicalCode", "code": "D002893", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "G05.360.162.520.300.235.250" } } } ] }, { "@type": "MedicalWebPage", "name": "Chromosomes humains 4-5", "alternateName": "Chromosomes, Human, 4-5", "url": "https://questionsmedicales.fr/mesh/D002905", "about": { "@type": "MedicalCondition", "name": "Chromosomes humains 4-5", "code": { "@type": "MedicalCode", "code": "D002905", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "G05.360.162.520.300.280" } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Chromosomes humains de la paire 4", "alternateName": "Chromosomes, Human, Pair 4", "url": "https://questionsmedicales.fr/mesh/D002894", "about": { "@type": "MedicalCondition", "name": "Chromosomes humains de la paire 4", "code": { "@type": "MedicalCode", "code": "D002894", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "G05.360.162.520.300.280.285" } } }, { "@type": "MedicalWebPage", "name": "Chromosomes humains de la paire 5", "alternateName": "Chromosomes, Human, Pair 5", "url": "https://questionsmedicales.fr/mesh/D002895", "about": { "@type": "MedicalCondition", "name": "Chromosomes humains de la paire 5", "code": { "@type": "MedicalCode", "code": "D002895", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "G05.360.162.520.300.280.290" } } } ] }, { "@type": "MedicalWebPage", "name": "Chromosomes humains 6-12 et X", "alternateName": "Chromosomes, Human, 6-12 and X", "url": "https://questionsmedicales.fr/mesh/D002906", "about": { "@type": "MedicalCondition", "name": "Chromosomes humains 6-12 et X", "code": { "@type": "MedicalCode", "code": "D002906", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "G05.360.162.520.300.325" } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Chromosomes humains de la paire 6", "alternateName": "Chromosomes, Human, Pair 6", "url": "https://questionsmedicales.fr/mesh/D002896", "about": { "@type": "MedicalCondition", "name": "Chromosomes humains de la paire 6", "code": { "@type": "MedicalCode", "code": "D002896", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "G05.360.162.520.300.325.330" } } }, { "@type": "MedicalWebPage", "name": "Chromosomes humains de la paire 7", "alternateName": "Chromosomes, Human, Pair 7", "url": "https://questionsmedicales.fr/mesh/D002897", "about": { "@type": "MedicalCondition", "name": "Chromosomes humains de la paire 7", "code": { "@type": "MedicalCode", "code": "D002897", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "G05.360.162.520.300.325.335" } } }, { "@type": "MedicalWebPage", "name": "Chromosomes humains de la paire 8", "alternateName": "Chromosomes, Human, Pair 8", "url": "https://questionsmedicales.fr/mesh/D002898", "about": { "@type": "MedicalCondition", "name": "Chromosomes humains de la paire 8", "code": { "@type": "MedicalCode", "code": "D002898", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "G05.360.162.520.300.325.340" } } }, { "@type": "MedicalWebPage", "name": "Chromosomes humains de la paire 9", "alternateName": "Chromosomes, Human, Pair 9", "url": "https://questionsmedicales.fr/mesh/D002899", "about": { "@type": "MedicalCondition", "name": "Chromosomes humains de la paire 9", "code": { "@type": "MedicalCode", "code": "D002899", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "G05.360.162.520.300.325.345" } } }, { "@type": "MedicalWebPage", "name": "Chromosomes humains de la paire 10", "alternateName": "Chromosomes, Human, Pair 10", "url": "https://questionsmedicales.fr/mesh/D002879", "about": { "@type": "MedicalCondition", "name": "Chromosomes humains de la paire 10", "code": { "@type": "MedicalCode", "code": "D002879", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "G05.360.162.520.300.325.350" } } }, { "@type": "MedicalWebPage", "name": "Chromosomes humains de la paire 11", "alternateName": "Chromosomes, Human, Pair 11", "url": "https://questionsmedicales.fr/mesh/D002880", "about": { "@type": "MedicalCondition", "name": "Chromosomes humains de la paire 11", "code": { "@type": "MedicalCode", "code": "D002880", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "G05.360.162.520.300.325.355" } } }, { "@type": "MedicalWebPage", "name": "Chromosomes humains de la paire 12", "alternateName": "Chromosomes, Human, Pair 12", "url": "https://questionsmedicales.fr/mesh/D002881", "about": { "@type": "MedicalCondition", "name": "Chromosomes humains de la paire 12", "code": { "@type": "MedicalCode", "code": "D002881", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "G05.360.162.520.300.325.360" } } } ] }, { "@type": "MedicalWebPage", "name": "Chromosomes humains 13-15", "alternateName": "Chromosomes, Human, 13-15", "url": "https://questionsmedicales.fr/mesh/D002901", "about": { "@type": "MedicalCondition", "name": "Chromosomes humains 13-15", "code": { "@type": "MedicalCode", "code": "D002901", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "G05.360.162.520.300.370" } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Chromosomes humains de la paire 13", "alternateName": "Chromosomes, Human, Pair 13", "url": "https://questionsmedicales.fr/mesh/D002882", "about": { "@type": "MedicalCondition", "name": "Chromosomes humains de la paire 13", "code": { "@type": "MedicalCode", "code": "D002882", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "G05.360.162.520.300.370.375" } } }, { "@type": "MedicalWebPage", "name": "Chromosomes humains de la paire 14", "alternateName": "Chromosomes, Human, Pair 14", "url": "https://questionsmedicales.fr/mesh/D002883", "about": { "@type": "MedicalCondition", "name": "Chromosomes humains de la paire 14", "code": { "@type": "MedicalCode", "code": "D002883", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "G05.360.162.520.300.370.380" } } }, { "@type": "MedicalWebPage", "name": "Chromosomes humains de la paire 15", "alternateName": "Chromosomes, Human, Pair 15", "url": "https://questionsmedicales.fr/mesh/D002884", "about": { "@type": "MedicalCondition", "name": "Chromosomes humains de la paire 15", "code": { "@type": "MedicalCode", "code": "D002884", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "G05.360.162.520.300.370.385" } } } ] }, { "@type": "MedicalWebPage", "name": "Chromosomes humains 16-18", "alternateName": "Chromosomes, Human, 16-18", "url": "https://questionsmedicales.fr/mesh/D002902", "about": { "@type": "MedicalCondition", "name": "Chromosomes humains 16-18", "code": { "@type": "MedicalCode", "code": "D002902", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "G05.360.162.520.300.415" } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Chromosomes humains de la paire 16", "alternateName": "Chromosomes, Human, Pair 16", "url": "https://questionsmedicales.fr/mesh/D002885", "about": { "@type": "MedicalCondition", "name": "Chromosomes humains de la paire 16", "code": { "@type": "MedicalCode", "code": "D002885", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "G05.360.162.520.300.415.420" } } }, { "@type": "MedicalWebPage", "name": "Chromosomes humains de la paire 17", "alternateName": "Chromosomes, Human, Pair 17", "url": "https://questionsmedicales.fr/mesh/D002886", "about": { "@type": "MedicalCondition", "name": "Chromosomes humains de la paire 17", "code": { "@type": "MedicalCode", "code": "D002886", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "G05.360.162.520.300.415.425" } } }, { "@type": "MedicalWebPage", "name": "Chromosomes humains de la paire 18", "alternateName": "Chromosomes, Human, Pair 18", "url": "https://questionsmedicales.fr/mesh/D002887", "about": { "@type": "MedicalCondition", "name": "Chromosomes humains de la paire 18", "code": { "@type": "MedicalCode", "code": "D002887", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "G05.360.162.520.300.415.430" } } } ] }, { "@type": "MedicalWebPage", "name": "Chromosomes humains 19-20", "alternateName": "Chromosomes, Human, 19-20", "url": "https://questionsmedicales.fr/mesh/D002903", "about": { "@type": "MedicalCondition", "name": "Chromosomes humains 19-20", "code": { "@type": "MedicalCode", "code": "D002903", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "G05.360.162.520.300.460" } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Chromosomes humains de la paire 19", "alternateName": "Chromosomes, Human, Pair 19", "url": "https://questionsmedicales.fr/mesh/D002888", "about": { "@type": "MedicalCondition", "name": "Chromosomes humains de la paire 19", "code": { "@type": "MedicalCode", "code": "D002888", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "G05.360.162.520.300.460.465" } } }, { "@type": "MedicalWebPage", "name": "Chromosomes humains de la paire 20", "alternateName": "Chromosomes, Human, Pair 20", "url": "https://questionsmedicales.fr/mesh/D002890", "about": { "@type": "MedicalCondition", "name": "Chromosomes humains de la paire 20", "code": { "@type": "MedicalCode", "code": "D002890", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "G05.360.162.520.300.460.470" } } } ] }, { "@type": "MedicalWebPage", "name": "Chromosomes humains 21-22 et Y", "alternateName": "Chromosomes, Human, 21-22 and Y", "url": "https://questionsmedicales.fr/mesh/D002904", "about": { "@type": "MedicalCondition", "name": "Chromosomes humains 21-22 et Y", "code": { "@type": "MedicalCode", "code": "D002904", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "G05.360.162.520.300.505" } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Chromosomes humains de la paire 21", "alternateName": "Chromosomes, Human, Pair 21", "url": "https://questionsmedicales.fr/mesh/D002891", "about": { "@type": "MedicalCondition", "name": "Chromosomes humains de la paire 21", "code": { "@type": "MedicalCode", "code": "D002891", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "G05.360.162.520.300.505.510" } } }, { "@type": "MedicalWebPage", "name": "Chromosomes humains de la paire 22", "alternateName": "Chromosomes, Human, Pair 22", "url": "https://questionsmedicales.fr/mesh/D002892", "about": { "@type": "MedicalCondition", "name": "Chromosomes humains de la paire 22", "code": { "@type": "MedicalCode", "code": "D002892", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "G05.360.162.520.300.505.515" } } } ] } ], "about": { "@type": "MedicalCondition", "name": "Chromosomes humains", "alternateName": "Chromosomes, Human", "code": { "@type": "MedicalCode", "code": "D002877", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "Glennis A Logsdon", "url": "https://questionsmedicales.fr/author/Glennis%20A%20Logsdon", "affiliation": { "@type": "Organization", "name": "Department of Genome Sciences, University of Washington School of Medicine, Seattle, WA, USA." } }, { "@type": "Person", "name": "Karen H Miga", "url": "https://questionsmedicales.fr/author/Karen%20H%20Miga", "affiliation": { "@type": "Organization", "name": "Department of Biomolecular Engineering, University of California Santa Cruz, Santa Cruz, CA, USA." } }, { "@type": "Person", "name": "Arang Rhie", "url": "https://questionsmedicales.fr/author/Arang%20Rhie", "affiliation": { "@type": "Organization", "name": "Genome Informatics Section, Computational and Statistical Genomics Branch, National Human Genome Research Institute, National Institutes of Health, Bethesda, MD, USA." } }, { "@type": "Person", "name": "Sergey Koren", "url": "https://questionsmedicales.fr/author/Sergey%20Koren", "affiliation": { "@type": "Organization", "name": "Genome Informatics Section, Computational and Statistical Genomics Branch, National Human Genome Research Institute, National Institutes of Health, Bethesda, MD, USA." } }, { "@type": "Person", "name": "Jennifer L Gerton", "url": "https://questionsmedicales.fr/author/Jennifer%20L%20Gerton", "affiliation": { "@type": "Organization", "name": "Stowers Institute for Medical Research, Kansas City, MO, USA." } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "Artificial Intelligence-Based PTEN Loss Assessment as an Early Predictor of Prostate Cancer Metastasis After Surgery: A Multicenter Retrospective Study.", "datePublished": "2023-06-19", "url": "https://questionsmedicales.fr/article/37343766", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.modpat.2023.100241" } }, { "@type": "ScholarlyArticle", "name": "Systemic Therapy of Premenopausal Patients with Early Stage Hormone Receptor-Positive, HER2-Negative Breast Cancer - Controversies and Standards in Healthcare.", "datePublished": "2023-05-23", "url": "https://questionsmedicales.fr/article/37614683", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1055/a-2073-1887" } }, { "@type": "ScholarlyArticle", "name": "Cardiac Safety and Efficacy of SB3 Trastuzumab Biosimilar for ERBB2-Positive Early Breast Cancer: Secondary Analysis of a Randomized Clinical Trial.", "datePublished": "2023-04-03", "url": "https://questionsmedicales.fr/article/37022687", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1001/jamanetworkopen.2023.5822" } }, { "@type": "ScholarlyArticle", "name": "Circulating tumor DNA in molecular assessment feasibly predicts early progression of pancreatic cancer that cannot be identified via initial imaging.", "datePublished": "2023-03-23", "url": "https://questionsmedicales.fr/article/36959222", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1038/s41598-023-31051-7" } }, { "@type": "ScholarlyArticle", "name": "Hypofractionated whole breast irradiation in association with hypofractionated or normofractionated boost to the tumor bed in early breast cancer: tolerance and efficacy analysis.", "datePublished": "2023-03-22", "url": "https://questionsmedicales.fr/article/36947361", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1007/s12094-023-03124-6" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "Phénomènes génétiques", "item": "https://questionsmedicales.fr/mesh/D055614" }, { "@type": "ListItem", "position": 3, "name": "Structures génétiques", "item": "https://questionsmedicales.fr/mesh/D040342" }, { "@type": "ListItem", "position": 4, "name": "Chromosomes", "item": "https://questionsmedicales.fr/mesh/D002875" }, { "@type": "ListItem", "position": 5, "name": "Chromosomes de mammifère", "item": "https://questionsmedicales.fr/mesh/D033481" }, { "@type": "ListItem", "position": 6, "name": "Chromosomes humains", "item": "https://questionsmedicales.fr/mesh/D002877" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : Chromosomes humains - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur Chromosomes humains", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2025-05-11", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Diagnostic", "headline": "Diagnostic sur Chromosomes humains", "description": "Comment diagnostiquer une anomalie chromosomique ?\nQuels tests génétiques sont disponibles ?\nQuels signes indiquent un problème chromosomique ?\nQuand faire un test de dépistage chromosomique ?\nQuel rôle joue l'échographie dans le diagnostic ?", "url": "https://questionsmedicales.fr/mesh/D002877?mesh_terms=Early+Detection+of+Cancer&page=1000#section-diagnostic" }, { "@type": "MedicalWebPage", "name": "Symptômes", "headline": "Symptômes sur Chromosomes humains", "description": "Quels sont les symptômes des syndromes chromosomiques ?\nComment se manifestent les troubles liés aux chromosomes ?\nLes anomalies chromosomiques causent-elles des douleurs ?\nY a-t-il des symptômes spécifiques au syndrome de Down ?\nLes troubles chromosomiques affectent-ils le comportement ?", "url": "https://questionsmedicales.fr/mesh/D002877?mesh_terms=Early+Detection+of+Cancer&page=1000#section-symptômes" }, { "@type": "MedicalWebPage", "name": "Prévention", "headline": "Prévention sur Chromosomes humains", "description": "Peut-on prévenir les anomalies chromosomiques ?\nQuel rôle joue la santé maternelle ?\nLes tests de dépistage prénatal sont-ils efficaces ?\nL'alimentation influence-t-elle les anomalies chromosomiques ?\nLes antécédents familiaux augmentent-ils les risques ?", "url": "https://questionsmedicales.fr/mesh/D002877?mesh_terms=Early+Detection+of+Cancer&page=1000#section-prévention" }, { "@type": "MedicalWebPage", "name": "Traitements", "headline": "Traitements sur Chromosomes humains", "description": "Quels traitements existent pour les anomalies chromosomiques ?\nLa thérapie génique est-elle une option ?\nComment gérer les symptômes des syndromes chromosomiques ?\nLes médicaments peuvent-ils aider ?\nY a-t-il des interventions précoces recommandées ?", "url": "https://questionsmedicales.fr/mesh/D002877?mesh_terms=Early+Detection+of+Cancer&page=1000#section-traitements" }, { "@type": "MedicalWebPage", "name": "Complications", "headline": "Complications sur Chromosomes humains", "description": "Quelles complications peuvent survenir avec des anomalies chromosomiques ?\nLes anomalies chromosomiques affectent-elles la fertilité ?\nY a-t-il des risques de maladies associées ?\nLes complications peuvent-elles être traitées ?\nLes personnes atteintes ont-elles besoin de soins continus ?", "url": "https://questionsmedicales.fr/mesh/D002877?mesh_terms=Early+Detection+of+Cancer&page=1000#section-complications" }, { "@type": "MedicalWebPage", "name": "Facteurs de risque", "headline": "Facteurs de risque sur Chromosomes humains", "description": "Quels sont les facteurs de risque pour les anomalies chromosomiques ?\nL'âge des parents influence-t-il les risques ?\nLes expositions environnementales sont-elles un risque ?\nLes maladies génétiques augmentent-elles les risques ?\nLe mode de vie peut-il influencer les risques ?", "url": "https://questionsmedicales.fr/mesh/D002877?mesh_terms=Early+Detection+of+Cancer&page=1000#section-facteurs de risque" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Comment diagnostiquer une anomalie chromosomique ?", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "Un caryotype est réalisé pour examiner le nombre et la structure des chromosomes." } }, { "@type": "Question", "name": "Quels tests génétiques sont disponibles ?", "position": 2, "acceptedAnswer": { "@type": "Answer", "text": "Les tests incluent l'analyse de l'ADN, le caryotype et le séquençage génomique." } }, { "@type": "Question", "name": "Quels signes indiquent un problème chromosomique ?", "position": 3, "acceptedAnswer": { "@type": "Answer", "text": "Des malformations congénitales, des retards de développement ou des troubles de la fertilité." } }, { "@type": "Question", "name": "Quand faire un test de dépistage chromosomique ?", "position": 4, "acceptedAnswer": { "@type": "Answer", "text": "Il est recommandé lors de grossesses à risque ou d'antécédents familiaux d'anomalies." } }, { "@type": "Question", "name": "Quel rôle joue l'échographie dans le diagnostic ?", "position": 5, "acceptedAnswer": { "@type": "Answer", "text": "L'échographie peut détecter des anomalies physiques pouvant indiquer des problèmes chromosomiques." } }, { "@type": "Question", "name": "Quels sont les symptômes des syndromes chromosomiques ?", "position": 6, "acceptedAnswer": { "@type": "Answer", "text": "Les symptômes varient, incluant des retards mentaux, des malformations et des troubles comportementaux." } }, { "@type": "Question", "name": "Comment se manifestent les troubles liés aux chromosomes ?", "position": 7, "acceptedAnswer": { "@type": "Answer", "text": "Ils peuvent se manifester par des anomalies physiques, des problèmes de croissance ou des troubles neurologiques." } }, { "@type": "Question", "name": "Les anomalies chromosomiques causent-elles des douleurs ?", "position": 8, "acceptedAnswer": { "@type": "Answer", "text": "Elles ne causent pas directement de douleurs, mais peuvent entraîner des complications douloureuses." } }, { "@type": "Question", "name": "Y a-t-il des symptômes spécifiques au syndrome de Down ?", "position": 9, "acceptedAnswer": { "@type": "Answer", "text": "Oui, incluant un visage plat, des yeux en amande et un tonus musculaire faible." } }, { "@type": "Question", "name": "Les troubles chromosomiques affectent-ils le comportement ?", "position": 10, "acceptedAnswer": { "@type": "Answer", "text": "Oui, certains peuvent entraîner des troubles du comportement ou des difficultés d'apprentissage." } }, { "@type": "Question", "name": "Peut-on prévenir les anomalies chromosomiques ?", "position": 11, "acceptedAnswer": { "@type": "Answer", "text": "Certaines anomalies ne peuvent pas être prévenues, mais des conseils génétiques peuvent aider." } }, { "@type": "Question", "name": "Quel rôle joue la santé maternelle ?", "position": 12, "acceptedAnswer": { "@type": "Answer", "text": "Une bonne santé maternelle avant et pendant la grossesse peut réduire certains risques chromosomiques." } }, { "@type": "Question", "name": "Les tests de dépistage prénatal sont-ils efficaces ?", "position": 13, "acceptedAnswer": { "@type": "Answer", "text": "Oui, ils peuvent détecter certaines anomalies chromosomiques avant la naissance." } }, { "@type": "Question", "name": "L'alimentation influence-t-elle les anomalies chromosomiques ?", "position": 14, "acceptedAnswer": { "@type": "Answer", "text": "Une alimentation équilibrée et des suppléments d'acide folique peuvent réduire certains risques." } }, { "@type": "Question", "name": "Les antécédents familiaux augmentent-ils les risques ?", "position": 15, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des antécédents familiaux d'anomalies chromosomiques peuvent augmenter le risque de récurrence." } }, { "@type": "Question", "name": "Quels traitements existent pour les anomalies chromosomiques ?", "position": 16, "acceptedAnswer": { "@type": "Answer", "text": "Les traitements varient selon les symptômes et peuvent inclure thérapies, chirurgie ou médicaments." } }, { "@type": "Question", "name": "La thérapie génique est-elle une option ?", "position": 17, "acceptedAnswer": { "@type": "Answer", "text": "La thérapie génique est en recherche pour certaines anomalies, mais n'est pas encore largement disponible." } }, { "@type": "Question", "name": "Comment gérer les symptômes des syndromes chromosomiques ?", "position": 18, "acceptedAnswer": { "@type": "Answer", "text": "La gestion inclut des soins médicaux, des thérapies physiques et des soutiens éducatifs." } }, { "@type": "Question", "name": "Les médicaments peuvent-ils aider ?", "position": 19, "acceptedAnswer": { "@type": "Answer", "text": "Oui, certains médicaments peuvent traiter des symptômes spécifiques comme l'anxiété ou l'hyperactivité." } }, { "@type": "Question", "name": "Y a-t-il des interventions précoces recommandées ?", "position": 20, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des interventions précoces en éducation et en thérapie sont cruciales pour le développement." } }, { "@type": "Question", "name": "Quelles complications peuvent survenir avec des anomalies chromosomiques ?", "position": 21, "acceptedAnswer": { "@type": "Answer", "text": "Les complications incluent des problèmes de santé chroniques, des retards de développement et des troubles mentaux." } }, { "@type": "Question", "name": "Les anomalies chromosomiques affectent-elles la fertilité ?", "position": 22, "acceptedAnswer": { "@type": "Answer", "text": "Oui, certaines anomalies peuvent entraîner des problèmes de fertilité chez les hommes et les femmes." } }, { "@type": "Question", "name": "Y a-t-il des risques de maladies associées ?", "position": 23, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les personnes avec des anomalies chromosomiques peuvent avoir un risque accru de certaines maladies." } }, { "@type": "Question", "name": "Les complications peuvent-elles être traitées ?", "position": 24, "acceptedAnswer": { "@type": "Answer", "text": "Certaines complications peuvent être gérées avec des traitements médicaux ou des interventions." } }, { "@type": "Question", "name": "Les personnes atteintes ont-elles besoin de soins continus ?", "position": 25, "acceptedAnswer": { "@type": "Answer", "text": "Oui, un suivi médical régulier est souvent nécessaire pour gérer les complications à long terme." } }, { "@type": "Question", "name": "Quels sont les facteurs de risque pour les anomalies chromosomiques ?", "position": 26, "acceptedAnswer": { "@type": "Answer", "text": "Les facteurs incluent l'âge maternel avancé, des antécédents familiaux et certaines expositions environnementales." } }, { "@type": "Question", "name": "L'âge des parents influence-t-il les risques ?", "position": 27, "acceptedAnswer": { "@type": "Answer", "text": "Oui, l'âge avancé des parents, surtout de la mère, augmente le risque d'anomalies chromosomiques." } }, { "@type": "Question", "name": "Les expositions environnementales sont-elles un risque ?", "position": 28, "acceptedAnswer": { "@type": "Answer", "text": "Certaines expositions, comme les radiations ou les produits chimiques, peuvent augmenter les risques." } }, { "@type": "Question", "name": "Les maladies génétiques augmentent-elles les risques ?", "position": 29, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des antécédents de maladies génétiques dans la famille peuvent accroître le risque d'anomalies." } }, { "@type": "Question", "name": "Le mode de vie peut-il influencer les risques ?", "position": 30, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des habitudes comme le tabagisme ou l'alcool peuvent augmenter le risque d'anomalies chromosomiques." } } ] } ] }

Sous-catégories

29 au total
└─

Chromosomes humains 1-3

Chromosomes, Human, 1-3 D002900 - G05.360.162.520.300.235
└─

Chromosomes humains 4-5

Chromosomes, Human, 4-5 D002905 - G05.360.162.520.300.280
└─

Chromosomes humains 6-12 et X

Chromosomes, Human, 6-12 and X D002906 - G05.360.162.520.300.325
└─

Chromosomes humains 13-15

Chromosomes, Human, 13-15 D002901 - G05.360.162.520.300.370
└─

Chromosomes humains 16-18

Chromosomes, Human, 16-18 D002902 - G05.360.162.520.300.415
└─

Chromosomes humains 19-20

Chromosomes, Human, 19-20 D002903 - G05.360.162.520.300.460
└─

Chromosomes humains 21-22 et Y

Chromosomes, Human, 21-22 and Y D002904 - G05.360.162.520.300.505
└─└─

Chromosomes humains de la paire 1

Chromosomes, Human, Pair 1 D002878 - G05.360.162.520.300.235.240
└─└─

Chromosomes humains de la paire 2

Chromosomes, Human, Pair 2 D002889 - G05.360.162.520.300.235.245
└─└─

Chromosomes humains de la paire 3

Chromosomes, Human, Pair 3 D002893 - G05.360.162.520.300.235.250
└─└─

Chromosomes humains de la paire 4

Chromosomes, Human, Pair 4 D002894 - G05.360.162.520.300.280.285
└─└─

Chromosomes humains de la paire 5

Chromosomes, Human, Pair 5 D002895 - G05.360.162.520.300.280.290
└─└─

Chromosomes humains de la paire 6

Chromosomes, Human, Pair 6 D002896 - G05.360.162.520.300.325.330
└─└─

Chromosomes humains de la paire 7

Chromosomes, Human, Pair 7 D002897 - G05.360.162.520.300.325.335
└─└─

Chromosomes humains de la paire 8

Chromosomes, Human, Pair 8 D002898 - G05.360.162.520.300.325.340
└─└─

Chromosomes humains de la paire 9

Chromosomes, Human, Pair 9 D002899 - G05.360.162.520.300.325.345
└─└─

Chromosomes humains de la paire 10

Chromosomes, Human, Pair 10 D002879 - G05.360.162.520.300.325.350
└─└─

Chromosomes humains de la paire 11

Chromosomes, Human, Pair 11 D002880 - G05.360.162.520.300.325.355
└─└─

Chromosomes humains de la paire 12

Chromosomes, Human, Pair 12 D002881 - G05.360.162.520.300.325.360
└─└─

Chromosomes humains de la paire 13

Chromosomes, Human, Pair 13 D002882 - G05.360.162.520.300.370.375
└─└─

Chromosomes humains de la paire 14

Chromosomes, Human, Pair 14 D002883 - G05.360.162.520.300.370.380
└─└─

Chromosomes humains de la paire 15

Chromosomes, Human, Pair 15 D002884 - G05.360.162.520.300.370.385
└─└─

Chromosomes humains de la paire 16

Chromosomes, Human, Pair 16 D002885 - G05.360.162.520.300.415.420
└─└─

Chromosomes humains de la paire 17

Chromosomes, Human, Pair 17 D002886 - G05.360.162.520.300.415.425
└─└─

Chromosomes humains de la paire 18

Chromosomes, Human, Pair 18 D002887 - G05.360.162.520.300.415.430
└─└─

Chromosomes humains de la paire 19

Chromosomes, Human, Pair 19 D002888 - G05.360.162.520.300.460.465
└─└─

Chromosomes humains de la paire 20

Chromosomes, Human, Pair 20 D002890 - G05.360.162.520.300.460.470
└─└─

Chromosomes humains de la paire 21

Chromosomes, Human, Pair 21 D002891 - G05.360.162.520.300.505.510
└─└─

Chromosomes humains de la paire 22

Chromosomes, Human, Pair 22 D002892 - G05.360.162.520.300.505.515

Sources (10000 au total)

Cardiac Safety and Efficacy of SB3 Trastuzumab Biosimilar for ERBB2-Positive Early Breast Cancer: Secondary Analysis of a Randomized Clinical Trial.

Trastuzumab has been the standard of care for the treatment of patients with ERBB2-positive breast cancer; however, cardiac events have been reported. This long-term follow-up study provides clinical ... To compare cardiac safety and efficacy between SB3 and TRZ for patients with ERBB2-positive early or locally advanced breast cancer after up to 6 years of follow-up.... This prespecified secondary analysis of a randomized clinical trial, conducted from April 2016 to January 2021, included patients with ERBB2-positive early or locally advanced breast cancer from a mul... In the original trial, patients were randomized to either SB3 or TRZ with concomitant neoadjuvant chemotherapy for 8 cycles (4 cycles of docetaxel followed by 4 cycles of fluorouracil, epirubicin, and... The primary outcomes were the incidence of symptomatic congestive heart failure and asymptomatic, significant decrease in left ventricular ejection fraction (LVEF). The secondary outcomes were event-f... A total of 538 female patients were included (median age, 51 years [range, 22-65 years]). Baseline characteristics were comparable between the SB3 and TRZ groups. Cardiac safety was monitored for 367 ... In this secondary analysis of a randomized clinical trial, SB3 demonstrated cardiac safety and survival comparable to those of TRZ after up to 6 years of follow-up in patients with ERBB2-positive earl... ClinicalTrials.gov Identifier: NCT02771795....

Circulating tumor DNA in molecular assessment feasibly predicts early progression of pancreatic cancer that cannot be identified via initial imaging.

Molecular assessment using circulating tumor DNA (ctDNA) has not been well-defined. We recruited 61 pancreatic cancer (PC) patients who underwent initial computed tomography (CT) imaging study during ...

Hypofractionated whole breast irradiation in association with hypofractionated or normofractionated boost to the tumor bed in early breast cancer: tolerance and efficacy analysis.

The boost to the tumor bed improves local control in breast cancer and it is an important part of the breast conserving therapy. However, information about the use of a hypofractionated boost is spars... A total of 96 women with early breast cancer undergoing breast-conserving surgery and hypofractionated whole breast irradiation (WBI) were retrospectively analyzed divided into hypofractionated boost ... The median follow-up was 49.5 months (26-67). Median age was 57 years (36-82). Sixty-six patients (68.7%) were younger than 60 years at the time of boost and 30 (31.2%) were older than 60 years who re... Hypofractionated WBI associated with HB treatment is a viable option in the management of conservative breast therapy given the good tolerance and similar local control....

Analysis of risk factors for lymph node metastasis and prognosis study in patients with early gastric cancer: A SEER data-based study.

Lymph node status is an important factor in determining the prognosis of patients with early gastric cancer (EGC) and preoperative diagnosis of lymph node metastasis (LNM) has some limitations. This s... Clinicopathological data of EGC patients was collected from the public Surveillance, Epidemiology, and End Results (SEER) database. Univariate and multivariate logistic regression was used to identify... A total of 3993 EGC patients were randomly allocated to a training cohort (n=2797) and a validation cohort (n=1196). An external cohort of 106 patients from the Second Hospital of Lanzhou University w... In this study, we identified risk factors and independent prognostic factors for the development of LNM in EGC patients, and developed a relatively accurate model to predict the development of LNM in ...

Comparison of the effects of endoscopic submucosal dissection and laparoscopic distal radical surgery on the rehabilitation and quality of life of patients with early gastric cancer.

This study was designed to compare the effects of endoscopic submucosal dissection (ESD) and laparoscopic distal radical surgery (LDRS) on patient rehabilitation and quality of life (QoL) in patients ... The clinical data of 52 patients with early GC admitted to Wuhan Union Hospital from January 2018 to December 2020 were retrospectively analyzed. Among them, 32 patients who underwent LDRS were assign... The laparoscopic group showed a significantly lower complete resection rate than the endoscopic group (P=0.030). The endoscopic group experienced notably less intraoperative blood loss and operation t... With significantly better efficacy than that of LDRS, ESD is beneficial to postoperative rehabilitation and can improve the QoL of patients, and both schemes cause no significant effect on the recurre...

Establishment and validation of a multigene model to predict the risk of relapse in hormone receptor-positive early-stage Chinese breast cancer patients.

Breast cancer patients who are positive for hormone receptor typically exhibit a favorable prognosis. It is controversial whether chemotherapy is necessary for them after surgery. Our study aimed to e... In this study, differentially expressed genes (DEGs) were identified between relapse and nonrelapse breast cancer groups based on RNA sequencing. Gene set enrichment analysis (GSEA) was performed to i... A total of 234 out of 487 patients were enrolled in this study, and 1588 DEGs were identified between the relapse and nonrelapse groups. GSEA results showed that immune-related pathways were enriched ... A multigene model was established from RNA-sequencing data to direct risk classification and predict relapse of hormone receptor-positive breast cancer in Chinese patients. Utilization of the model co...

Impact of age on indication for chemotherapy in early breast cancer patients: results from 104 German institutions from 2008 to 2017.

Today, the decision to treat patients with chemotherapy for early breast cancer (EBC) is made based on the patient's individual risk stratification and tumor biology. In cases with chemotherapy indica... The study separately analyzed chemotherapy use among six age cohorts of EBC patients who had been treated at 104 German breast units between January 2008 and December 2017.... In total, 124,084 patients were included, 46,279 (37.3%) of whom had received chemotherapy. For 44,765 of these cases, detailed information on treatment was available. Within this cohort, chemotherapy... The data from the nationwide German cohort reveal relevant age-dependent discrepancies concerning the use of chemotherapy for EBC....